Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
J Transl Med. 2008 May 1;6:22. doi: 10.1186/1479-5876-6-22.
J Transl Med. 2008.
PMID: 18452610
Free PMC article.
Clinical Trial.
Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
Straatsma BR, Nusinowitz S, Young TA, Gordon LK, Chun MW, Rosen C, Seja E, Economou JS, Glaspy JA, Bozon V, Gomez-Navarro J, Ribas A.
Straatsma BR, et al.
Am J Ophthalmol. 2007 Jun;143(6):958-969. doi: 10.1016/j.ajo.2007.02.035. Epub 2007 Apr 16.
Am J Ophthalmol. 2007.
PMID: 17434437
Clinical Trial.
Item in Clipboard
Phase I/II trial of tremelimumab in patients with metastatic melanoma.
Camacho LH, Antonia S, Sosman J, Kirkwood JM, Gajewski TF, Redman B, Pavlov D, Bulanhagui C, Bozon VA, Gomez-Navarro J, Ribas A.
Camacho LH, et al. Among authors: bozon va.
J Clin Oncol. 2009 Mar 1;27(7):1075-81. doi: 10.1200/JCO.2008.19.2435. Epub 2009 Jan 12.
J Clin Oncol. 2009.
PMID: 19139427
Clinical Trial.
Item in Clipboard
Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.
Reuben JM, Lee BN, Li C, Gomez-Navarro J, Bozon VA, Parker CA, Hernandez IM, Gutierrez C, Lopez-Berestein G, Camacho LH.
Reuben JM, et al. Among authors: bozon va.
Cancer. 2006 Jun 1;106(11):2437-44. doi: 10.1002/cncr.21854.
Cancer. 2006.
PMID: 16615096
Free article.
Clinical Trial.
Item in Clipboard
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors.
Adjei AA, LoRusso P, Ribas A, Sosman JA, Pavlick A, Dy GK, Zhou X, Gangolli E, Kneissl M, Faucette S, Neuwirth R, Bózon V.
Adjei AA, et al.
Invest New Drugs. 2017 Feb;35(1):47-58. doi: 10.1007/s10637-016-0391-2. Epub 2016 Sep 21.
Invest New Drugs. 2017.
PMID: 27650277
Free PMC article.
Clinical Trial.
Item in Clipboard
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.
Dahlman KB, Xia J, Hutchinson K, Ng C, Hucks D, Jia P, Atefi M, Su Z, Branch S, Lyle PL, Hicks DJ, Bozon V, Glaspy JA, Rosen N, Solit DB, Netterville JL, Vnencak-Jones CL, Sosman JA, Ribas A, Zhao Z, Pao W.
Dahlman KB, et al.
Cancer Discov. 2012 Sep;2(9):791-7. doi: 10.1158/2159-8290.CD-12-0097. Epub 2012 Jul 13.
Cancer Discov. 2012.
PMID: 22798288
Free PMC article.
Item in Clipboard
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
Dummer R, Schadendorf D, Ascierto PA, Arance A, Dutriaux C, Di Giacomo AM, Rutkowski P, Del Vecchio M, Gutzmer R, Mandala M, Thomas L, Demidov L, Garbe C, Hogg D, Liszkay G, Queirolo P, Wasserman E, Ford J, Weill M, Sirulnik LA, Jehl V, Bozón V, Long GV, Flaherty K.
Dummer R, et al.
Lancet Oncol. 2017 Apr;18(4):435-445. doi: 10.1016/S1470-2045(17)30180-8. Epub 2017 Mar 9.
Lancet Oncol. 2017.
PMID: 28284557
Clinical Trial.
Item in Clipboard
Cite
Cite